Hearing Loss Trial, Recruiting (NCT05028972)

Hearing Loss Trial, Recruiting NCT05028972 Sponsor: VA Office of Research and Development Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT05028972 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You speak English
You are visiting the emergency department for a low or medium urgency reason (not a life-threatening emergency)
You have scored 10 or higher on a hearing difficulty screening questionnaire, or answered "yes" to a single question about hearing problems
You are able to understand and agree to take part in research on your own

Who may not be able to join:

You are not able to agree to take part in research on your own
You are being seen in the emergency department for a high urgency or life-threatening reason
You scored below 10 on the hearing difficulty screening questionnaire and answered "no" to the single hearing question
You do not speak English
You use a cochlear implant (a surgically placed hearing device)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joshua Chodosh, MD MSHS, VA NY Harbor Healthcare System, New York, NY

Phone: (310) 478-3711

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05028972

Sponsor: VA Office of Research and Development

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: (310) 478-3711

More information: https://clinicaltrials.gov/study/NCT05028972

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You speak English
You are visiting the emergency department for a low or medium urgency reason (not a life-threatening emergency)
You have scored 10 or higher on a hearing difficulty screening questionnaire, or answered "yes" to a single question about hearing problems
You are able to understand and agree to take part in research on your own

Who may not be able to join:

You are not able to agree to take part in research on your own
You are being seen in the emergency department for a high urgency or life-threatening reason
You scored below 10 on the hearing difficulty screening questionnaire and answered "no" to the single hearing question
You do not speak English
You use a cochlear implant (a surgically placed hearing device)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

VA Office of Research and Development

Registry

ClinicalTrials.gov

Start date

8 December 2021

Est. completion

30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

ED 3-day Readmissions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov